---
title: "Ainos | 8-K: FY2026 Q2 Revenue: USD 152"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294740427.md"
datetime: "2026-08-03T21:22:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294740427.md)
  - [en](https://longbridge.com/en/news/294740427.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294740427.md)
---

# Ainos | 8-K: FY2026 Q2 Revenue: USD 152

Revenue: As of FY2026 Q2, the actual value is USD 152.

EPS: As of FY2026 Q2, the actual value is USD -0.62.

EBIT: As of FY2026 Q2, the actual value is USD -4.395 M.

Ainos, Inc. reported its financial results for the quarter ended June 30, 2026.

#### Revenues

-   For the three months ended June 30, 2026, revenues were $152, compared to $4,663 for the same period in 2025.
-   For the six months ended June 30, 2026, revenues were $313, compared to $110,870 for the same period in 2025.

#### Gross Profit (Loss)

-   Gross profit for the three months ended June 30, 2026, was $99, compared to $3,726 for the same period in 2025.
-   Gross loss for the six months ended June 30, 2026, was -$503, compared to a gross profit of $91,700 for the same period in 2025.

#### Operating Expenses

-   Research and development expenses for the three months ended June 30, 2026, were $1,850,409, a decrease from $1,911,800 in 2025.
-   Selling, general and administrative expenses for the three months ended June 30, 2026, were $2,548,776, an increase from $1,837,613 in 2025.
-   Total operating expenses for the three months ended June 30, 2026, were $4,399,185, compared to $3,749,413 for the same period in 2025.
-   Research and development expenses for the six months ended June 30, 2026, were $3,540,269, compared to $3,635,884 for the same period in 2025.
-   Selling, general and administrative expenses for the six months ended June 30, 2026, were $3,141,961, compared to $3,364,374 for the same period in 2025.
-   Total operating expenses for the six months ended June 30, 2026, were $6,682,230, compared to $7,000,258 for the same period in 2025.

#### Loss from Operations

-   Loss from operations for the three months ended June 30, 2026, was -$4,399,086, compared to -$3,745,687 for the same period in 2025.
-   Loss from operations for the six months ended June 30, 2026, was -$6,682,733, compared to -$6,908,558 for the same period in 2025.

#### Net Loss

-   Net loss for the three months ended June 30, 2026, was -$4,594,731, compared to -$4,084,990 for the same period in 2025.
-   Net loss for the six months ended June 30, 2026, was -$7,054,531, compared to -$7,371,012 for the same period in 2025.

#### Cash and Cash Equivalents

-   Cash and cash equivalents were $1,422,912 as of June 30, 2026, an increase from $417,353 as of December 31, 2025.

#### Total Current Assets

-   Total current assets were $2,188,538 as of June 30, 2026, compared to $1,138,799 as of December 31, 2025.

#### Total Assets

-   Total assets were $19,561,485 as of June 30, 2026, compared to $20,871,108 as of December 31, 2025.

#### Total Current Liabilities

-   Total current liabilities were $16,277,500 as of June 30, 2026, a significant increase from $1,078,683 as of December 31, 2025.

#### Total Liabilities

-   Total liabilities were $16,277,500 as of June 30, 2026, compared to $13,308,526 as of December 31, 2025.

#### Total Stockholders’ Equity

-   Total stockholders’ equity was $3,283,985 as of June 30, 2026, compared to $7,562,582 as of December 31, 2025.

#### Operational Metrics

-   Since December 2025, Ainos, Inc.’s AI Nose has accumulated approximately 613 million industrial smell data records, primarily from semiconductor manufacturing environments.

#### Outlook / Guidance

-   Ainos, Inc. anticipates its ongoing activities will contribute to broader revenue generation opportunities in the second half of 2026. The company is focused on executing its commercialization strategy, expanding real-world applications, and advancing its Smell AI Platform. Management also emphasized a commitment to disciplined capital allocation, financial management, operational efficiency, and strategic deployment activities.

### Related Stocks

- [AIMD.US](https://longbridge.com/en/quote/AIMD.US.md)

## Related News & Research

- [AIMD: AI Nose deployments expanded in Q2 2026, but net losses and low revenue continued](https://longbridge.com/en/news/294740599.md)
- [VASRO Research Highlights Ainos' Progress in Scaling Smell AI Commercialization and Compounding Its Smell ID Dataset | AIMD Stock News](https://longbridge.com/en/news/295416069.md)
- [Algorhythm Holdings to Announce its Financial Results for the Second Quarter of 2026](https://longbridge.com/en/news/295634378.md)
- [CitroTech Provides Q2 2026 Business Update in Letter to Shareholders](https://longbridge.com/en/news/295561956.md)
- [Can Gold Make a New High in 2026?](https://longbridge.com/en/news/295569739.md)